Aclaris Therapeutics, Inc. (ACRS)

NASDAQ: ACRS · Real-Time Price · USD

1.630

+0.060 (3.82%)

Aug 8, 2025, 1:51 PM - Market open

R1 RCM Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2020
Period Ending	Aug '25 Aug 8, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2016 - 2020
Market Capitalization	176	265	74	1,050	890	278	Upgrade
Market Cap Growth	96.14%	256.84%	-92.92%	17.97%	220.59%	254.99%	Upgrade
Enterprise Value	-13	95	-110	805	650	238	Upgrade
Last Close Price	1.57	2.48	1.05	15.75	14.54	6.47	Upgrade
PS Ratio	9.63	14.18	2.38	35.30	131.67	42.84	Upgrade
PB Ratio	1.18	1.71	0.47	5.32	4.51	7.38	Upgrade
P/TBV Ratio	1.21	1.71	0.47	5.51	4.68	9.10	Upgrade
EV/Sales Ratio	-	5.06	-	27.04	96.09	36.79	Upgrade
Debt / Equity Ratio	0.02	0.02	0.02	0.01	0.02	0.38	Upgrade
Asset Turnover	-	0.09	0.14	0.12	0.04	0.08	Upgrade
Quick Ratio	-	3.88	3.86	9.94	8.38	3.69	Upgrade
Current Ratio	-	3.99	4.16	10.56	8.94	3.87	Upgrade
Return on Equity (ROE)	-	-84.46%	-49.88%	-44.01%	-77.33%	-95.12%	Upgrade
Return on Assets (ROA)	-	-15.72%	-31.67%	-21.04%	-25.38%	-35.87%	Upgrade
Return on Capital (ROIC)	-25.79%	-20.59%	-39.70%	-26.60%	-32.43%	-48.16%	Upgrade
Earnings Yield	-77.00%	-49.76%	-118.96%	-8.28%	-10.21%	-18.37%	Upgrade
FCF Yield	-	-7.61%	-107.07%	-6.49%	-5.89%	-14.08%	Upgrade
Buyback Yield / Dilution	-44.96%	-10.73%	-7.05%	-14.95%	-33.36%	-2.94%	Upgrade

Updated Aug 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q